Atlas Trials

Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over

Clinical trial NCT06515418 · TERMINATED

Trial details

NCT number
NCT06515418
Sponsor
BioAge Labs, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2024-06-27
Primary completion
2025-02-06
Enrollment
204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.